Report cover image

Buprenorphine Hydrochloride Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 126 Pages
SKU # APRC20260355

Description

Summary

According to APO Research, the global Buprenorphine Hydrochloride market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Buprenorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Buprenorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Buprenorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Buprenorphine Hydrochloride include Arevipharma, Faranshimi, Johnson Matthey, Mallinckrodt, Micro Orgo Chem, Noramco, Resonance-labs, Rusan Pharma and Siegfried, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buprenorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buprenorphine Hydrochloride.

The report will help the Buprenorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.



The Buprenorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Buprenorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Buprenorphine Hydrochloride Segment by Company

Arevipharma
Faranshimi
Johnson Matthey
Mallinckrodt
Micro Orgo Chem
Noramco
Resonance-labs
Rusan Pharma
Siegfried
Sun Pharma
Unichemlabs
Sanofi
Buprenorphine Hydrochloride Segment by Type

Tablets
Injection
Buprenorphine Hydrochloride Segment by Application

Analgesic
Opioid Antagonist
Buprenorphine Hydrochloride Segment by Region


North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Buprenorphine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Buprenorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

126 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Buprenorphine Hydrochloride Market Size (2020-2031)
2.2.2 Global Buprenorphine Hydrochloride Sales (2020-2031)
2.2.3 Global Buprenorphine Hydrochloride Market Average Price (2020-2031)
2.3 Buprenorphine Hydrochloride by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Tablets
2.3.3 Injection
2.4 Buprenorphine Hydrochloride by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Analgesic
2.4.3 Opioid Antagonist
3 Market Competitive Landscape by Manufacturers
3.1 Global Buprenorphine Hydrochloride Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Buprenorphine Hydrochloride Sales (Kg) of Manufacturers (2020-2025)
3.3 Global Buprenorphine Hydrochloride Revenue of Manufacturers (2020-2025)
3.4 Global Buprenorphine Hydrochloride Average Price by Manufacturers (2020-2025)
3.5 Global Buprenorphine Hydrochloride Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Buprenorphine Hydrochloride, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Buprenorphine Hydrochloride, Product Type & Application
3.8 Global Manufacturers of Buprenorphine Hydrochloride, Established Date
3.9 Global Buprenorphine Hydrochloride Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Arevipharma
4.1.1 Arevipharma Company Information
4.1.2 Arevipharma Business Overview
4.1.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Arevipharma Buprenorphine Hydrochloride Product Portfolio
4.1.5 Arevipharma Recent Developments
4.2 Faranshimi
4.2.1 Faranshimi Company Information
4.2.2 Faranshimi Business Overview
4.2.3 Faranshimi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Faranshimi Buprenorphine Hydrochloride Product Portfolio
4.2.5 Faranshimi Recent Developments
4.3 Johnson Matthey
4.3.1 Johnson Matthey Company Information
4.3.2 Johnson Matthey Business Overview
4.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Johnson Matthey Buprenorphine Hydrochloride Product Portfolio
4.3.5 Johnson Matthey Recent Developments
4.4 Mallinckrodt
4.4.1 Mallinckrodt Company Information
4.4.2 Mallinckrodt Business Overview
4.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Mallinckrodt Buprenorphine Hydrochloride Product Portfolio
4.4.5 Mallinckrodt Recent Developments
4.5 Micro Orgo Chem
4.5.1 Micro Orgo Chem Company Information
4.5.2 Micro Orgo Chem Business Overview
4.5.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Micro Orgo Chem Buprenorphine Hydrochloride Product Portfolio
4.5.5 Micro Orgo Chem Recent Developments
4.6 Noramco
4.6.1 Noramco Company Information
4.6.2 Noramco Business Overview
4.6.3 Noramco Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Noramco Buprenorphine Hydrochloride Product Portfolio
4.6.5 Noramco Recent Developments
4.7 Resonance-labs
4.7.1 Resonance-labs Company Information
4.7.2 Resonance-labs Business Overview
4.7.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Resonance-labs Buprenorphine Hydrochloride Product Portfolio
4.7.5 Resonance-labs Recent Developments
4.8 Rusan Pharma
4.8.1 Rusan Pharma Company Information
4.8.2 Rusan Pharma Business Overview
4.8.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Rusan Pharma Buprenorphine Hydrochloride Product Portfolio
4.8.5 Rusan Pharma Recent Developments
4.9 Siegfried
4.9.1 Siegfried Company Information
4.9.2 Siegfried Business Overview
4.9.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Siegfried Buprenorphine Hydrochloride Product Portfolio
4.9.5 Siegfried Recent Developments
4.10 Sun Pharma
4.10.1 Sun Pharma Company Information
4.10.2 Sun Pharma Business Overview
4.10.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Sun Pharma Buprenorphine Hydrochloride Product Portfolio
4.10.5 Sun Pharma Recent Developments
4.11 Unichemlabs
4.11.1 Unichemlabs Company Information
4.11.2 Unichemlabs Business Overview
4.11.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Unichemlabs Buprenorphine Hydrochloride Product Portfolio
4.11.5 Unichemlabs Recent Developments
4.12 Sanofi
4.12.1 Sanofi Company Information
4.12.2 Sanofi Business Overview
4.12.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Sanofi Buprenorphine Hydrochloride Product Portfolio
4.12.5 Sanofi Recent Developments
5 Global Buprenorphine Hydrochloride Market Scenario by Region
5.1 Global Buprenorphine Hydrochloride Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Buprenorphine Hydrochloride Sales by Region: 2020-2031
5.2.1 Global Buprenorphine Hydrochloride Sales by Region: 2020-2025
5.2.2 Global Buprenorphine Hydrochloride Sales by Region: 2026-2031
5.3 Global Buprenorphine Hydrochloride Revenue by Region: 2020-2031
5.3.1 Global Buprenorphine Hydrochloride Revenue by Region: 2020-2025
5.3.2 Global Buprenorphine Hydrochloride Revenue by Region: 2026-2031
5.4 North America Buprenorphine Hydrochloride Market Facts & Figures by Country
5.4.1 North America Buprenorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Buprenorphine Hydrochloride Sales by Country (2020-2031)
5.4.3 North America Buprenorphine Hydrochloride Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Buprenorphine Hydrochloride Market Facts & Figures by Country
5.5.1 Europe Buprenorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Buprenorphine Hydrochloride Sales by Country (2020-2031)
5.5.3 Europe Buprenorphine Hydrochloride Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Buprenorphine Hydrochloride Market Facts & Figures by Country
5.6.1 Asia Pacific Buprenorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Buprenorphine Hydrochloride Sales by Country (2020-2031)
5.6.3 Asia Pacific Buprenorphine Hydrochloride Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Buprenorphine Hydrochloride Market Facts & Figures by Country
5.7.1 South America Buprenorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Buprenorphine Hydrochloride Sales by Country (2020-2031)
5.7.3 South America Buprenorphine Hydrochloride Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Buprenorphine Hydrochloride Market Facts & Figures by Country
5.8.1 Middle East and Africa Buprenorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Buprenorphine Hydrochloride Sales by Country (2020-2031)
5.8.3 Middle East and Africa Buprenorphine Hydrochloride Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Buprenorphine Hydrochloride Sales by Type (2020-2031)
6.1.1 Global Buprenorphine Hydrochloride Sales by Type (2020-2031) & (Kg)
6.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Type (2020-2031)
6.2 Global Buprenorphine Hydrochloride Revenue by Type (2020-2031)
6.2.1 Global Buprenorphine Hydrochloride Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Type (2020-2031)
6.3 Global Buprenorphine Hydrochloride Price by Type (2020-2031)
7 Segment by Application
7.1 Global Buprenorphine Hydrochloride Sales by Application (2020-2031)
7.1.1 Global Buprenorphine Hydrochloride Sales by Application (2020-2031) & (Kg)
7.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Application (2020-2031)
7.2 Global Buprenorphine Hydrochloride Revenue by Application (2020-2031)
7.2.1 Global Buprenorphine Hydrochloride Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Application (2020-2031)
7.3 Global Buprenorphine Hydrochloride Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Buprenorphine Hydrochloride Value Chain Analysis
8.1.1 Buprenorphine Hydrochloride Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Buprenorphine Hydrochloride Production Mode & Process
8.2 Buprenorphine Hydrochloride Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Buprenorphine Hydrochloride Distributors
8.2.3 Buprenorphine Hydrochloride Customers
9 Global Buprenorphine Hydrochloride Analyzing Market Dynamics
9.1 Buprenorphine Hydrochloride Industry Trends
9.2 Buprenorphine Hydrochloride Industry Drivers
9.3 Buprenorphine Hydrochloride Industry Opportunities and Challenges
9.4 Buprenorphine Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.